Objective
to report the long-term survival of DM patients with multivessel disease who underwent PCI or CABG
Study
multicentre, randomised trial
Population
Freedom trial 1,900 patients. Of these 943 participated in Freedom follow-up trial
Endpoints
all-cause mortality after median follow-up of 7.5 years


Conclusion
coronary revascularisation with CABG in patients with DM and MVD is associated with long term lower all-cause mortality than PCI
Farkouh et al. J Am Coll Cardiol. 2019;73:629-38